Davis R M Inc
- SEC CIK
- 0000891287
- Latest filing
- Aug 14, 2026
NVO holding history
Novo Nordisk A S in every 13F filed by Davis R M Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVO overviewAll 13F holders of NVOFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −1,563−100.0% | Sold out | Holders |
| Q2 2024 | 1,563 | $223.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 1,563 | $200.7K | <0.1% | +1,563 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −9,172−100.0% | Sold outConverted for a 2-for-1 split | Holders |
| Q2 2023 | 4,586 | $742.0K | <0.1% | +24+0.5% | Added | Holders |
| Q1 2023 | 4,562 | $726.0K | <0.1% | −113−2.4% | Reduced | Holders |
| Q4 2022 | 4,675 | $633.0K | <0.1% | +310+7.1% | Added | Holders |
| Q3 2022 | 4,365 | $435.0K | <0.1% | +103+2.4% | Added | Holders |
| Q2 2022 | 4,262 | $475.0K | <0.1% | +112+2.7% | Added | Holders |
| Q1 2022 | 4,150 | $461.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 4,150 | $465.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 4,150 | $398.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 4,150 | $348.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 4,150 | $280.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.